<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8-jof-07-00014">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Posteraro</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Tumbarello</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>De Pascale</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Liberto</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Vallecoccia</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>De Carolis</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Di Gravio</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Trecarichi</surname>
    <given-names>E.M.</given-names>
   </name>
   <name>
    <surname>Sanguinetti</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Antonelli</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>(1,3)-Î²-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study</article-title>
  <source>J. Antimicrob. Chemother.</source>
  <year>2016</year>
  <volume>71</volume>
  <fpage>2262</fpage>
  <lpage>2269</lpage>
  <pub-id pub-id-type="doi">10.1093/jac/dkw112</pub-id>
  <pub-id pub-id-type="pmid">27125554</pub-id>
 </element-citation>
</ref>
